Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROXYPROPYL CELLULOSE vs IBREXAFUNGERP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HYDROXYPROPYL CELLULOSE vs IBREXAFUNGERP: Safety Overview

Metric HYDROXYPROPYL CELLULOSE IBREXAFUNGERP
Total FAERS Reports 296 129
Deaths Reported 0 6
Death Rate N/A 4.7%
Hospitalizations 3 9
Average Patient Age 64.1 yrs 44.4 yrs
% Female Patients 91.2% 85.2%
FDA Approval Date Approved Prior to Jan 1, 1982 Jun 1, 2021
Manufacturer Bausch & Lomb Incorporated N/A
Route OPHTHALMIC N/A
Marketing Status Discontinued Prescription